Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CMA1 | P23946 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | GSK3A | P49840 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.43 |
| ▸ | PTGIR | P43119 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
| ▸ | MMP13 | P45452 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15429645 | 0.91 | CMA1 (0.58) | CMA1SIGMAR1ALDH1A1MAPTKDM4E | |
| Hydrochloric Acid SCHEMBL2530335 | 0.90 | CMA1 (0.56) | CMA1SIGMAR1ALDH1A1MAPTKDM4E | |
| SCHEMBL1009271 | 0.81 | SIGMAR1 (0.47) | CMA1SIGMAR1ALDH1A1MAPTKDM4E | |
| Bromide SCHEMBL2196195 | 0.80 | SIGMAR1 (0.46) | CMA1SIGMAR1ALDH1A1MAPTKDM4E | |
| SCHEMBL27329 | 0.80 | IDO1 (0.58) | ALDH1A1ALOX15SMN1; SMN2TAAR1 | |
| SCHEMBL4181089 | 0.80 | IDO1 (0.58) | ALDH1A1ALOX15SMN1; SMN2TAAR1 | |
| Iodide SCHEMBL11084431 | 0.79 | SIGMAR1 (0.45) | CMA1SIGMAR1ALDH1A1MAPTKDM4E | |
| SCHEMBL1475480 | 0.78 | IDO1 (0.56) | ALDH1A1ALOX15SMN1; SMN2TAAR1 | |
| Methoxymethane SCHEMBL28284584 | 0.78 | IDO1 (0.56) | ALDH1A1ALOX15SMN1; SMN2TAAR1 | |
| SCHEMBL1477048 | 0.78 | IDO1 (0.56) | ALDH1A1ALOX15SMN1; SMN2TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8632914-B2 | Triazolium and imidazolium salts and uses thereof | UNIVERSITY HEALTH NETWORK (CA) | 2014-01-21 | — | — | US | disclosed |
| US-20110257235-A1 | TRIAZOLIUM AND IMIDAZOLIUM SALTS AND USES THEREOF | UNIVERSITY HEALTH NETWORK (CA) | 2011-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110257235-A1 | TRIAZOLIUM AND IMIDAZOLIUM SALTS AND USES THEREOF | ARG2, ARG1, CIT | CMA1 3252/4885SIGMAR1 209/4885ALDH1A1 3979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.